Laboratory of Integrative Neuroendocrinology, Department of Biology, York University, Toronto, Ontario, Canada.
PLoS One. 2010 Dec 3;5(12):e15201. doi: 10.1371/journal.pone.0015201.
Nesfatin-1 is a recently discovered anorexigen encoded in the precursor peptide, nucleobindin-2 (NUCB2) in mammals. To date, nesfatin-1 has not been described in any non-mammalian species, although some information is available in the sequenced genomes of several species. Our objective was to characterize nesfatin-1 in fish.
METHODOLOGY/PRINCIPAL FINDINGS: In the present study, we employed molecular, immunohistochemical, and physiological studies to characterize the structure, distribution, and appetite regulatory effects of nesfatin-1 in a non-mammalian vertebrate. A very high conservation in NUCB2 sequences, especially in the nesfatin-1 region was found in lower vertebrates. Abundant expression of NUCB2 mRNA was detected in several tissues including the brain and liver of goldfish. Nesfatin-1-like immunoreactive cells are present in the feeding regulatory nucleus of the hypothalamus and in the gastrointestinal tract of goldfish. Approximately 6-fold increase in NUCB2 mRNA levels was found in the liver after 7-day food-deprivation, and a similar increase was also found after short-term fasting. This points toward a possible liver specific role for NUCB2 in the control of metabolism during food-deprivation. Meanwhile, ∼2-fold increase at 1 and 3 h post-feeding and an ∼3-fold reduction after a 7-day food-deprivation was observed in NUCB2 mRNA in the goldfish hypothalamus. In vivo, a single intraperitoneal injection of the full-length native (goldfish; gf) nesfatin-1 at a dose of 50 ng/g body weight induced a 23% reduction of food intake one hour post-injection in goldfish. Furthermore, intracerebroventricular injection of gfnesfatin-1 at a dose of 5 ng/g body weight resulted in ∼50% reduction in food intake.
CONCLUSIONS/SIGNIFICANCE: Our results provide molecular, anatomical and functional evidences to support potential anorectic and metabolic roles for endogenous nesfatin-1 in goldfish. Collectively, we provide novel information on NUCB2 in non-mammals and an anorexigenic role for nesfatin-1 in goldfish.
Nesfatin-1 是一种最近在哺乳动物前体肽核结合蛋白 2(NUCB2)中发现的厌食肽。迄今为止,尚未在任何非哺乳动物物种中描述过 nesfatin-1,尽管在几个物种的测序基因组中可以获得一些信息。我们的目标是研究鱼类中的 nesfatin-1。
方法/主要发现:在本研究中,我们采用分子、免疫组织化学和生理学研究来描述非哺乳动物脊椎动物中 nesfatin-1 的结构、分布和食欲调节作用。在下等脊椎动物中发现 NUCB2 序列,特别是 nesfatin-1 区域高度保守。在金鱼的几种组织中,包括大脑和肝脏,都检测到大量的 NUCB2 mRNA 表达。Nesfatin-1 样免疫反应细胞存在于下丘脑的摄食调节核和金鱼的胃肠道中。经过 7 天的禁食后,肝脏中的 NUCB2 mRNA 水平增加了约 6 倍,而短期禁食后也发现了类似的增加。这表明在禁食期间,NUCB2 可能在肝脏中发挥代谢控制的特定作用。同时,在金鱼下丘脑,禁食后 1 小时和 3 小时 NUCB2 mRNA 增加约 2 倍,禁食 7 天后减少约 3 倍。在体内,金鱼全长天然(gf)nesfatin-1 以 50ng/g 体重的剂量单次腹腔注射,可在注射后 1 小时使摄食量减少 23%。此外,以 5ng/g 体重的剂量向脑室内注射 gfnesfatin-1 可使摄食量减少约 50%。
结论/意义:我们的结果提供了分子、解剖和功能证据,支持内源性 nesfatin-1 在金鱼中具有潜在的厌食和代谢作用。总的来说,我们为非哺乳动物的 NUCB2 提供了新信息,并为金鱼的 nesfatin-1 提供了厌食作用。